Old Web
English
Sign In
Acemap
>
authorDetail
>
Y Kawata
Y Kawata
Chugai Pharmaceutical Co.
Physical therapy
Medicine
Family medicine
Placebo
Population
2
Papers
11
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Efficacy and safety of satralizumab from two phase 3 trials in neuromyelitis optica spectrum disorder
2020
Investigative Ophthalmology & Visual Science
Zdenka Haskova
Benjamin Frishberg
Jérôme De Seze
Brian G Weinshenker
Y Terada
Y Kawata
Athos Gianella-Borradori
Christian von Büdingen
Gaelle Klingelschmitt
Anthony Traboulsee
Takashi Yamamura
Show All
Source
Cite
Save
Citations (1)
Efficacy of satralizumab (SA237) in subgroups of patients in SAkuraSky: a Phase III double-blind, placebo-controlled, add-on study in patients with neuromyelitis optica spectrum disorder (NMOSD) (S43.008)
2019
Neurology
Takashi Yamamura
Ingo Kleiter
Kazuo Fujihara
Jacqueline Palace
Benjamin Greenberg
B. Zakrzewska-Pniewska
Francesco Patti
C. P. Tsai
Albert Saiz
M Haramura
Y Terada
Y Kawata
J. De Seze
Show All
Source
Cite
Save
Citations (10)
1